Literature DB >> 33713565

Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19).

Mahboobeh Karimi-Galougahi1, Shima Arastou1, Sara Haseli1.   

Abstract

Entities:  

Keywords:  COVID-19; mucormycosis; sinusitis

Year:  2021        PMID： 33713565     DOI： 10.1002/alr.22785

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN： 2042-6976            Impact factor:   3.858


× No keyword cloud information.
  29 in total

Review 1.  Mucormycosis in COVID-19: A systematic review of literature.

Authors:  Shivaraj Nagalli; Nidhi Shankar Kikkeri
Journal:  Infez Med       Date:  2021-12-10

Review 2.  CT Findings of COVID-19-associated Pulmonary Mucormycosis: A Case Series and Literature Review.

Authors:  Mandeep Garg; Nidhi Prabhakar; Valliappan Muthu; Shameema Farookh; Harsimran Kaur; Vikas Suri; Ritesh Agarwal
Journal:  Radiology       Date:  2021-08-31       Impact factor: 11.105

Review 3.  Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.

Authors:  Yasasve Madhavan; Kadambari Vijay Sai; Dilip Kumar Shanmugam; Aashabharathi Manimaran; Karthigadevi Guruviah; Yugal Kishore Mohanta; Divyambika Catakapatri Venugopal; Tapan Kumar Mohanta; Nanaocha Sharma; Saravanan Muthupandian
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

Review 4.  COVID-19 and Fungal Diseases.

Authors:  Kyoung-Ho Oh; Seung-Hoon Lee
Journal:  Antibiotics (Basel)       Date:  2022-06-15

5.  COVID-19-associated fungal infections in Iran: A systematic review.

Authors:  Tina Nazari; Fatemeh Sadeghi; Alireza Izadi; Setayesh Sameni; Shahram Mahmoudi
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

Review 6.  High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections.

Authors:  Kinal Bhatt; Arjola Agolli; Mehrie H Patel; Radhika Garimella; Madhuri Devi; Efrain Garcia; Harshad Amin; Carlos Domingue; Roberto Guerra Del Castillo; Marcos Sanchez-Gonzalez
Journal:  Discoveries (Craiova)       Date:  2021-03-31

Review 7.  COVID-19 associated mucormycosis - An emerging threat.

Authors:  Chien-Ming Chao; Chih-Cheng Lai; Wen-Liang Yu
Journal:  J Microbiol Immunol Infect       Date:  2022-01-13       Impact factor: 10.273

Review 8.  Mucormycosis infection in patients with COVID-19: A systematic review.

Authors:  SeyedAhmad SeyedAlinaghi; Amirali Karimi; Alireza Barzegary; Zahra Pashaei; Amir Masoud Afsahi; Sanam Alilou; Nazanin Janfaza; Alireza Shojaei; Fatemeh Afroughi; Parsa Mohammadi; Yasna Soleimani; Newsha Nazarian; Ava Amiri; Marcarious M Tantuoyir; Shahram Oliaei; Esmaeil Mehraeen; Omid Dadras
Journal:  Health Sci Rep       Date:  2022-02-28

9.  Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.

Authors:  Farzad Pakdel; Kazem Ahmadikia; Mohammadreza Salehi; Azin Tabari; Rozita Jafari; Golfam Mehrparvar; Yasaman Rezaie; Shahin Rajaeih; Neda Alijani; Aleksandra Barac; Alireza Abdollahi; Sadegh Khodavaisy
Journal:  Mycoses       Date:  2021-07-01       Impact factor: 4.931

Review 10.  COVID-19 and mucormycosis superinfection: the perfect storm.

Authors:  Jaffar A Al-Tawfiq; Saad Alhumaid; Abeer N Alshukairi; Mohamad-Hani Temsah; Mazin Barry; Abbas Al Mutair; Ali A Rabaan; Awadh Al-Omari; Raghavendra Tirupathi; Manaf AlQahtani; Salma AlBahrani; Kuldeep Dhama
Journal:  Infection       Date:  2021-07-24       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.